SpecialtiesQuestion

When do you entertain a diagnosis of HLA-negative antibody mediated rejection in lung transplant recipients?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

Should a patient who requires definitive treatment for prostate cancer as a pre-transplant requirement be strictly required to complete their course prior to transplant/initiation of immunosuppression?

What dose of methotrexate do you typically continue to prevent antibody formation when adding infliximab for sarcoidosis?

Does your working phenotype for ‘new PAH after LT’ (occult POPH vs PAH unmasked after HPS resolution vs distinct post-LT vasculopathy) change what you actually do—specifically, who you screen more aggressively and when you initiate PAH therapy?

Is it acceptable to list a patient for lung transplantation who has a BMI between 30 and 35 kg/m² and is otherwise a highly suitable candidate, without first requiring weight loss to bring their BMI below 30?

Do you prefer awake ECMO as a bridge to lung transplantation in a spontaneously breathing patient with end-stage lung disease who is deteriorating on the waitlist, rather than proceeding to intubation and mechanical ventilation?

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.